KRAS and colorectal carcinoma: It was interesting to observe that, except for the last two, all other pathways were more methylated (indicated by positive delta beta) for CRC tissue and the magnitude of hyper-methylation (although very minimum) was significantly greater in tumors with the KRAS mutation (indicated by the ANOVA interaction p-value).